References
- Anderson RT, Marrero D, Skovlund SE, Self-reported compliance with insulin injection therapy in subjects with type 1 and 2 diabetes. Diabetologia 2003;46:A275.
- Albrecht G, Hoogstraten J. Satisfaction as determination of compliance. Community Dent Oral Epidemiol 1998;26:139–146.
- Cappelleri JC, Gerber RA, Kourides IA, Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care 2000;23:1799–1803.
- Peyrot M, Rubin RR. Validity and reliability of an instrument for assessing health-related quality of life and treatment preference. Diabetes Care 2005;28:53–58.
- Colman SS, Brod M, Potter LP, Cross-sectional 7-year follow-up of anxiety in primary care patients. Depress Anxiety 2004;19:105–111.
- Leidy NK, Revicki DA, Geneste B. Recommendations for evaluating the validity of quality of life claims for labeling and promotion. Value Health 1999;2:113–127.
- Revicki DA, Osoba D, Fairclough D, Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;9:887–900.
- Matza LS, Johnston JA, Faries DE, Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL). Qual Life Res 2007;16:1511–1520.
- Valensi P, Benroubi M, Borzi V, ; IMPROVE Study Group Expert Panel. The IMPROVETM study – a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts. Int J Clin Pract 2008;62:1809–1819.
- Brod M, Skovlund SE, Wittrup-Jensen K. Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience. Qual Life Res 2006;15: 481–491.
- Brod M, Cobden D, Lammert M, Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues. Health Qual Life Outcomes 2007;5:8.
- Brod M, Christensen T, Bushnell D. Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes. Qual Life Res 2007;16:1053–1063.
- Valensi P, Benroubi M, Borzi V, et al.; IMPROVE Study Group Expert Panel. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study. Int J Clin Pract 2009;63:522–531.
- Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
- Liang MH, Fossel AH, Larson MG: Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990;28: 632–642